3-amino-2-hydroxy-4-phenylbutanoic acid has been researched along with quinoxalines in 1 studies
| Studies (3-amino-2-hydroxy-4-phenylbutanoic acid) | Trials (3-amino-2-hydroxy-4-phenylbutanoic acid) | Recent Studies (post-2010) (3-amino-2-hydroxy-4-phenylbutanoic acid) | Studies (quinoxalines) | Trials (quinoxalines) | Recent Studies (post-2010) (quinoxalines) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 9,887 | 625 | 3,095 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handa, H; Higashida, S; Kimura, S; Komai, T; Mohri, H; Nishigaki, T; Oka, S; Sakurai, M; Shimada, K; Sugano, M; Suzuki-Sunagawa, H; Yabe, Y; Yagi, R; Yasuoka, A | 1 |
1 other study(ies) available for 3-amino-2-hydroxy-4-phenylbutanoic acid and quinoxalines
| Article | Year |
|---|---|
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid.
Topics: Amino Acid Sequence; Anti-HIV Agents; Base Sequence; Cell Line; DNA Primers; HIV Protease Inhibitors; HIV-1; Humans; Molecular Sequence Data; Phenylbutyrates; Quinoxalines; Sequence Homology, Amino Acid | 1997 |